BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Johnson & Johnson (JNJ) Bets $700 Million On MacroGenics, Inc. (MGNX)'s Blood Cancer Drug     12/22/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD)     12/22/2014
FDA Approves AbbVie (ABBV)'s All-Oral Hepatitis C Drug Viekira Pak     12/22/2014
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab     12/22/2014
AstraZeneca PLC (AZN) Grabs Accelerated FDA Approval for Lynparza     12/22/2014
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure     12/22/2014
NewLink Genetics, Merck & Co. (MRK) Nabs $30 Million Government Contract For Ebola     12/22/2014
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/19/2014
Eli Lilly (LLY), Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin     12/19/2014
Second Phase Of GlaxoSmithKline (GSK)'s Ebola Vaccine Delayed     12/19/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag     12/18/2014
TetraPhase Pharmaceuticals (TTPH) Surges As Antibiotic Succeeds In Late-Stage Trial     12/18/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax     12/18/2014
Pfizer (PFE) Shows Off Significant Data From Pregabalin CR Phase 3     12/18/2014
GlaxoSmithKline (GSK)'s Experimental Shingles Vaccine Hits Goal In Late-Stage Study     12/18/2014
 Featured Stories
People With Blood Groups A, B And AB At Higher Risk Of Type 2 Diabetes Than Group O, INSERM Study     12/22/2014
High Blood Sugar In Young Children With Type 1 Diabetes Linked To Changes In Brain Growth, Nemours Children's Clinic Study     12/22/2014
Parkinson’s Disease Reverted At A Experimental Stage, CINVESTAV Study     12/22/2014
OCD Patients' Brains Light Up To Reveal How Compulsive Habits Develop, University of Cambridge Study     12/22/2014
Rhode Island Hospital Researchers And An International Team Of Investigators Find Bacterial Infections Differ Based On A Country's Distance From The Equator And Spending On Health Care     12/22/2014
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
The Ebola Treatment You Know Nothing About     12/19/2014
Fifty Three Approved Drugs That May Block Ebola Infection, Mount Sinai Hospital Study     12/19/2014
Tooth Loss Linked To Slowing Mind And Body, University College London Study     12/19/2014
Bilberries May Counter Adverse Effects Of High-Fat Diets, University Of Eastern Finland Study     12/19/2014
Not Again! First Ever Case Of Anxiety-Induced Deja Vu, Sheffield Hallam University Study     12/19/2014
Standing On One Leg For 20 Seconds May Predict Stroke Risk, Kyoto University Study     12/19/2014
OTC Painkillers Linked To Reduced Skin Cancer Risk, University of London Study     12/19/2014
Low-Dose Lithium Prevents Parkinson's Symptoms In Aged Mice With A Human Mutation For The Disease, Buck Institute for Age Research Study     12/19/2014
Most Commonly Prescribed Glaucoma Drug Reduces Risk Of Vision Loss By More Than 50% Over 2 Years: Lancet     12/19/2014
 More News
AbbVie (ABBV) Receives U.S. FDA Approval Of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C     12/22/2014
Biocryst Pharmaceuticals (BCRX)'s RAPIVAB™ (Peramivir Injection) Receives FDA Approval For The Treatment Of Acute Uncomplicated Influenza     12/22/2014
AstraZeneca PLC (AZN) Release: LYNPARZA™ Approved By The FDA For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-Mutations     12/22/2014
Achillion Pharmaceuticals, Inc. (ACHN) Shows Potential For "Best-In-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422     12/22/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval Of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol For Treatment Of Children With Seasonal And Perennial Allergic Rhinitis     12/19/2014
Ligand Pharmaceuticals Inc. (LGND) Partner Pfizer (PFE) Receives European Marketing Authorization For DUAVIVE® (Conjugated Estrogens/Bazedoxifene) For Treatment Of Estrogen Deficiency Symptoms In Postmenopausal Women With A Uterus     12/19/2014
Roche (RHHBY) Provides Update On Gantenerumab Development Programme     12/19/2014
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer     12/19/2014
Cardio3 BioSciences Announces The Enrolment Of The 240th Patient For Its CHART-1 Phase 3 Clinical Trial For The Treatment Of Heart Failure     12/19/2014
AB Science (AB.PA): Report Of Positive Clinical Study Data In Metastatic Colorectal Cancer     12/19/2014
Innate Pharma (IPH.PA ): First Phase 2 Trial With IPH2201 Open In Head And Neck Cancer     12/19/2014
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF     12/19/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Results From The Phase 2 Borealis-1 Trial Of Apatorsen In The Treatment Of Metastatic Bladder Cancer     12/19/2014
Halozyme Therapeutics, Inc. (HALO) Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer     12/19/2014
St. Jude Children's Research Hospital Release: Cells Identified That Enhance Tumor Growth And Suppress Anti-Cancer Immune Attack     12/19/2014